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It has been suggested that nutritional factors may affect the risk of
cervical cancer. Numerous studies examined the relationships
between vitamins, carotenoids and cervical neoplasia (Schneider
and Shah, 1989; Potishman and Brinton, 1996). We previously
reported decreased serum retinol levels in women with cervical
dysplasia as compared with age-matched controls (Shimizu et al,
1996). However, most other studies have found no association of
risk of cervical neoplasia with either dietary or serum retinol
(Marshall et al, 1983; Harris et al, 1986; Brock et al, 1988; La
Vecchia et al, 1988; Palan et al, 1988, 1991; Verreault et al, 1989;
Cuzick et al, 1990; Ziegler et al, 1990; De Vet et al, 1991; Herrero
et al, 1991). Relationships of dietary carotenoids to risk of cervical
neoplasia have been inconsistent in previous studies (Marshall et
al, 1983; Harris et al, 1986; Brock et al, 1988; La Vecchia et al,
1988; Palan et al, 1988; Cuzick et al, 1990; Ziegler et al, 1990;
De Vet et al, 1991; Herrero et al, 1991; VanEenwyk et al, 1991).
However, the results from serologic data have more consistently
suggested a reduced risk associated with high serum carotenoid
level (Harris et al, 1986; Palan et al, 1988; Brock et al, 1988;
Verreault et al, 1989; Potishman et al, 1991; VanEenwyk et al,
1991; Batieha et al, 1993).
Epidemiological and laboratory evidence has supported the
conclusion that human papillomavirus (HPV) infection is a primary
causative agent for cervical cancer (Herrero, 1996). Nutritional
factors may be only correlates of human papillomavirus (HPV)
infection. Early epidemiological studies of HPV infection were
limited by poorly validated detection method, but recently improved
polymerase chain reaction (PCR)-based detection affords a greater
sensitivity and specificity for a broad spectrum of HPV types
(Schiffman, 1992). We determined HPV infection by PCR-based
assays and evaluated the relationships between dietary and serum
micronutrients and cervical dysplasia taking account of potential
confounding effects of HPV infection and other factors.
MATERIALS AND METHODS
Cases and controls for the present study were derived from women
attending Papanicolaou test screening at nine institutes affiliated to
the Japan Study Group of HPV and Cervical Cancer between June
1995 and July 1996. They returned to the institute about 1 week
later to receive the result of the test. For women with abnormal
findings, colposcopic examination was performed at that time. A
total of 167 women aged 55 years or younger with newly histolog-
ically confirmed cervical dysplasia formed the case group. All
histological diagnoses were reviewed by one pathologist. Their
diagnoses were 94 mild, 40 moderate and 33 severe dysplasia. For
each case, an institute- and age- (within 5 years) matched control
was selected from women with normal cervical cytology. The first
eligible match (if she refused to participate, the next eligible
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match) after the identification of case was approached. About 90%
of the first eligible controls agreed to participate in the study.
A self-administered questionnaire including demographic
factors, smoking and drinking habits, diet, reproductive history
and sexual behaviour was distributed to each case and control
when she visited the institute to know the result of Papanicolaou
test. Diet was assessed by asking about the intake amounts of 22
foods that are retinol- and carotene-rich during the past 7 days.
Daily intake of retinol and carotene were estimated using the
Standard Tables of Food Composition in Japan (4th revised edition
published by the Science and Technology Agency of Japan). The
detailed information about the dietary questionnaire including
validity was described elsewhere (Shimizu et al, 1996). A total of
167 cases and matched controls responded to the questionnaire.
Blood sampling as well as collection of cervical smear samples
were performed on the same day. Serum was isolated and frozen at
–80°C. The fraction of carotenoids, retinol and tocopherol of the
serum samples were extracted into n-hexane, and the concentra-
tions of a-carotene, b-carotene, cryptoxanthin, lutein/zeaxanthin,
lycopene, and a-tocopherol were determined by high-performance
liquid chromatography (HPLC) using a slight modification of
Nells and Leenheer’s method (Nells and De Leenheer, 1983). The
serum of cases and matched controls was assayed for micro-
nutrients on the same day, with the same reagent, and by the same
technician. Type V a-carotene, type IV b-carotene, lycopene
purchased from Sigma Co. Ltd (St Louis, MO, USA), b-crypto-
xanthin and zeaxanthin from Roche Co. Ltd (Basel, Switzerland),
and a-tocopherol from Eizai Co. Ltd (Tokyo, Japan) were used as
standards. Analytical conditions for the HPLC method were
described elsewhere (Ito et al, 1990).
For HPV detection, the swabs were placed into 2-ml phosphate-
buffered saline (PBS). The cell suspensions after vigorous vortexing
were frozen at –80°C and stored until the assay for detection of
HPV. The cellular DNA was extracted by standard sodium dodecyl
sulphate (SDS)-proteinase K producer. The PCR for the L1 region
was done by the partly modified method previously described by
Yoshikawa et al (1991). We used the consensus L1 primers
L1C1 (5¢-CGTAAACGTTTTCCCTATTTTTTT-3¢) (1 mM), L1C2
(5¢-TACCCTAAATACTCTGTATTG-3¢) (0.5 mM) and L1C2M
(5¢-TACCCTAAATACCCTATATTG-3¢) (0.5 mM) for the PCR.
HPV types were identified on the basis of the restriction fragment
length polymorphisms (RFLP). The PCR-based assay (L1-PCR)
can type at least 26 registered genital HPVs, namely types 6, 11, 16,
18, 30, 31, 33, 34, 35, 39, 42, 43, 44, 45, 51, 52, 53, 54, 55, 56, 58,
59, 61, 66, 68 and 70.
The HPV findings and risk of cervical dysplasia based on 167
pairs have been described elsewhere (Yoshikawa et al, 1999). As
we could not obtain blood samples from 12 cases and eight
controls, the present analysis was restricted to 152 matched pairs
with carotenoid data. These excluded cases and controls were
younger than the rest of each group respectively (the mean (s.d.)
ages were 32.7 (5.8) vs 40.9 (7.8) in cases and 35.8 (10.0) vs 41.0
(7.8) in controls). However, the distributions of other study vari-
ables in the excluded cases and controls were similar to those in
the rest of each group after controlling for age. The distribution of
diagnosis in 152 cases were 88 mild, 34 moderate and 30 severe
dysplasia.
To evaluate the associations of dietary and serum micronutri-
ents, odds ratios (ORs) and 95% confidence intervals (CIs) were
estimated using conditional logistic regression model. Each
micronutrient level was categorized by tertile according to the
distribution in controls. Test for linear trend was obtained by
assigning the median values to each category level. To distinguish
the independent effect of dietary or serum micronutrient on the
risk of cervical dysplasia, we calculated ORs with and without
adjustment for HPV test result (negative or positive) and smoking
status (current or non-smokers). Confounding effects of other vari-
ables such as number of births, age at first pregnancy, lifetime
number of sexual partners and age at first intercourse were also
evaluated by including them into the models. All statistical
analyses were done using the SAS programs (SAS Institute, Cary,
NC, USA).
RESULTS
There were no significant differences in retinol and carotene
intake between cases and controls (Table 1). Significantly lower
serum levels of a-carotene,  b-carotene and lycopene were
observed in cases.
In univariate analyses, there were significant inverse associa-
tions between serum levels of retinol, a-carotene,  b-carotene
and lycopene and risk of cervical dysplasia (Table 2). The
dose–response relationships were also statistically significant for
these variables. Serum a-carotene was significantly inversely
associated with risk of cervical dysplasia after controlling for HPV
infection and smoking status. The OR for the highest tertile of
lycopene was lowered to 0.28 after adjustment, but was of border-
line significance (P = 0.06). The dose–response for decreasing risk
Table 1 Selected characterisics of 152 matched pairs
Variables Cases Controls
Mean (s.d.) age (years) 40.8 (7.8) 41.2 (7.8)
Mean (s.d.) number of births 1.77 (1.13) 2.23 (1.08)a
Marital status (%)
Married 126 (85.7) 112 (75.7)
Separated/widowed 12 (8.2) 16 (10.8)
Never-married 9 (6.1) 20 (13.5)
Cigarette smoking (%)
Never 99 (67.4) 109 (74.7)
Former 13 (8.8) 17 (11.6)
Current 35 (23.8) 20 (13.7)
Age at first intercourse (%)
–18 14 (9.5) 15 (10.1)
19–23 104 (70.3) 86 (57.7)
24+ 30 (20.3) 48 (32.4)
Lifetime number of sexual partners (%)
0–1 68 (46.0) 88 (59.1)
2–3 47 (31.8) 39 (26.2)
4+ 33 (22.3) 22 (14.8)
HPV infection (%)
Negative 35 (24.0) 103 (85.1)
Positive 111 (76.0) 18 (14.9)b
Mean (s.d.) intake (mg)
Rentinol 576 (931) 388 (738)
Carotene 4402 (3694) 4567 (3836)
Mean (s.d.) serum micronutrient (mmol l–1)
Retinol 2.04 (0.68) 2.14 (0.63)
a-carotene 0.15 (0.11) 0.19 (0.13)a
b-carotene 1.08 (0.71) 1.34 (0.84)a
Zeaxanthin/lutein 0.93 (0.40) 1.02 (0.52)
Cryptoxanthin 0.84 (0.95) 0.71 (0.64)
Lycopene 0.55 (0.33) 0.65 (0.37)a
a-tocopherol 17.1 (5.62) 17.3 (4.31)
aP < 0.01 for t-test. The values for serum micronutrients was log-transformed
for t-test. bP < 0.001 for c2 test.1236 C Nagata et al
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with increasing lycopene level was slightly statistically significant.
The association of b-carotene with risk of cervical dysplasia was
not statistically significant after controlling for HPV infection and
smoking status.
Additional adjustments for number of births, marital status and
variables for sexual behaviours did not alter the results substan-
tially.
We further categorized HPV infection status according to HPV
type; high-risk HPVs (types 16 and 18), intermediate-risk HPVs
(types 31, 33, 51, 52, 56, 58, 59, 68 and 70) and low-risk HPVs
(types 6, 11, 42, 53, 54, 61 and 66 or unknown types). Adjusting
for HPV type instead of HPV positivity did not change the results
substantially (for example, the ORs for the second and the highest
tertiles of serum a-carotene were 0.23 and 0.17, respectively, after
controlling for HPV type and smoking status).
DISCUSSION
We found that high levels of serum a-carotene and lycopene were
associated with a decreased risk of cervical dysplasia. These asso-
ciations were not explained by confounding due to HPV infection
and other factors. We had to exclude 11 cases and 35 controls
without data on HPV infection or smoking status from the multi-
variate analyses. However, the results of univariate analyses
excluding them were similar to those based on the entire subjects.
The present study supports the hypothesis that carotenoids play
an important role in the genesis of cervical cancer. To our knowl-
edge, only three studies assessed the association between serum
micronutrients and risk of cervical neoplasia after allowing for
HPV infection. Potishman et al (1991) measured the same serum
markers as we did, but found that only b-carotene was significantly
Table 2 Odds ratios (ORs) of cervical dysplasia according to tertiles of dietary and serum micronutrients
Variable Number of OR Adjusteda OR
(median) cases/controls (95% CI) (95% CI)
Dietary retionol (mg)
1 (81.4) 50/49 1.00 1.00
2 (165.7) 40/47 0.72 (0.38–1.36) 0.51 (0.13–2.00)
3 (309.4) 56/49 1.05 (0.59–1.86) 2.02 (0.62–6.60)
P for trend 0.70 0.16
Dietary carotene (mg)
1 (1676) 44/49 1.00 1.00
2 (3528) 54/47 1.45 (0.75–2.78) 1.47 (0.41–5.33)
3 (6725) 48/49 1.19 (0.61–2.31) 2.34 (0.60–9.05)
P for trend 0.88 0.21
Serum micronutrients (mmol l–1)
Retinol
1 (1.56) 75/50 1.00 1.00
2 (2.10) 29/50 0.31 (0.16–0.61) 0.21 (0.05–0.83)
3 (2.65) 48/52 0.48 (0.25–0.91) 0.50 (0.14–1.80)
P for trend 0.03 0.32
a-carotene
1 (0.095) 84/50 1.00 1.00
2 (0.158) 45/51 0.49 (0.27–0.89) 0.19 (0.04–0.82)
3 (0.256) 23/51 0.27 (0.14–0.52) 0.16 (0.04–0.62)
P for trend 0.0001 0.01
b-carotene
1 (0.639) 65/50 1.00 1.00
2 (1.063) 57/50 0.89 (0.52–1.54) 1.13 (0.42–3.03)
3 (2.061) 30/52 0.45 (0.25–0.82) 0.65 (0.22–1.92)
P for trend 0.007 0.38
Zeaxanthin/lutein
1 (0.647) 68/51 1.00 1.00
2 (0.937) 40/49 0.63 (0.36–1.08) 0.69 (0.22–2.14)
3 (1.338) 44/52 0.64 (0.37–1.11) 0.53 (0.16–1.78)
P for trend 0.11 0.31
Cryptoxanthin
1 (0.228) 51/51 1.00 1.00
2 (0.467) 47/51 0.92 (0.52–1.63) 0.86 (0.29–2.57)
3 (1.256) 54/50 1.10 (0.61–1.97) 1.35 (0.46–4.02)
P for trend 0.66 0.56
Lycopene
1 (0.307) 69/51 1.00 1.00
2 (0.573) 45/51 0.58 (0.31–1.06) 0.53 (0.15–1.90)
3 (0.973) 38/50 0.53 (0.30–0.95) 0.28 (0.08–1.01)
P for trend 0.047 0.049
a-tocopherol
1 (13.8) 56/51 1.00 1.00
2 (16.9) 52/51 0.91 (0.53–1.59) 0.56 (0.18–1.96)
3 (20.8) 44/50 0.78 (0.44–1.41) 0.85 (0.28–2.61)
P for trend 0.68 0.80
aAdjusted for HPV infection and smoking.Serum carotenoids and cervical dysplasia 1237
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inversely associated with risk of invasive cervical cancer. In their
study, HPV infection was detected by filter in situ hybridization, as
used in early studies, which is less sensitive than the PCR method
(Schiffman, 1992). In the other two studies, Butterworth et al
(1992) measured only total carotenoids and Kwañniewska et al
(1996) measured only b-carotene. Reduced risk associated with
higher serum a-carotene was observed in the studies by
VanEenwyk et al (1991) and Batieha et al (1993), although HPV
infection was not adjusted for. Serum lycopene was significantly
inversely associated with risk of cervical neoplasia in these studies.
The multivariate analyses in our study showed that confounding
effect of HPV infection was not so great except that for the associ-
ation of b-carotene with risk of cervical dysplasia. Adjusting for
HPV infection and smoking status somewhat strengthened the
associations for retinol, a-carotene, and lycopene. Most previous
studies which found a negative association between serum
micronutrients and cervical neoplasia did not consider the effect of
HPV infection (Bernstein and Harris, 1984; Harris et al, 1986;
Brock et al, 1988; Palan et al, 1988; Verreault et al, 1989;
VanEenwyk et al, 1991; Batieha et al, 1993).
b-carotene as well as other carotenoids act as antioxidants
(Burton and Ingold, 1984), suggesting their potential usefulness in
disease prevention. Although data from cervical cancer chemo-
prevention trials failed to show a preventive effect of b-carotene
(Romney et al, 1997), other carotenoids such as a-carotene
and lycopene may prevent cervical cancer. It is also possible that
b-carotene may not work after the genesis of cervical dysplasia.
As the sera were not obtained from cases before the diagnosis of
cervical dysplasia, we cannot exclude the possibility that the
observed associations may be a consequence of the disease rather
than a reflection of its aetiology.
High intake of retinol and carotene were associated with
increased risk of cervical dysplasia, although they did not attain
statistical significance. If these are true, decreased serum
carotenoid in cases could not be explained by low intake of foods
rich in carotenoids. These findings also suggest that decrease in
serum carotenoids is a result rather a cause of disease. On the other
hand, there is a possibility that the observed positive associations
for dietary retinol and carotene are due to recall bias. It is also
possible that the assessment of nutrient intake was based on intake
amounts during the past week which may not have accurately
reflected dietary intakes at the relevant time.
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